Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
172 hedge funds and large institutions have $802M invested in Meridian Bioscience Inc in 2016 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 74 increasing their positions, 56 reducing their positions, and 19 closing their positions.
126% more call options, than puts
Call options by funds: $2.38M | Put options by funds: $1.05M
32% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 56
1% less capital invested
Capital invested by funds: $807M → $802M (-$4.82M)
2% less funds holding
Funds holding: 176 → 172 (-4)
11% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$8.27M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$6.96M |
| 3 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
+$5.28M |
| 4 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
+$4.75M |
| 5 |
FAM
Fred Alger Management
New York
|
+$4.41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
-$11.6M |
| 2 |
PP
Prudential plc
London, England,
United Kingdom
|
-$9.97M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$6.96M |
| 4 |
FAM
Fenimore Asset Management
Cobleskill,
New York
|
-$5.44M |
| 5 |
WBC
Westpac Banking Corp
Sydney,
Australia
|
-$4M |
VIVO Hedge Fund Activity: Q1 2016 in Review
172 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q1 2016, worth a combined $802M — down 0.6% from $807M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of VIVO and 17 opened new positions — a net loss of 2 holders — while 56 trimmed existing stakes and 74 added.
The largest buyer was Acadian Asset Management, adding an estimated $8.27M. The largest seller was Neuberger Berman Group, cutting an estimated $11.6M.
- 172 institutional investors held Meridian Bioscience Inc (VIVO) as of Q1 2016, down from 176 in Q4 2015.
- Funds reported $802M of Meridian Bioscience Inc stock for Q1 2016, down 0.6% quarter-over-quarter.
- 17 funds opened new Meridian Bioscience Inc positions in Q1 2016 and 19 closed out, a net change of -2 holders.
- The largest Meridian Bioscience Inc buyer in Q1 2016 was Acadian Asset Management, an estimated $8.27M added.
- The largest Meridian Bioscience Inc seller in Q1 2016 was Neuberger Berman Group, an estimated $11.6M sold.
Based on aggregated 13F filings for Q1 2016.